Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A view from industry.

M L Chapek1

  • 1MVP Laboratories, Inc., Ralston, NE 68127, USA. marylou@nfinity.com

Developments in Biologicals
|April 8, 2003
PubMed
Summary

Veterinary biologicals manufacturers in the United States favor humane testing but lack funds. Focusing on the 3Rs (replacement, reduction, refinement) and reasonable costs can free resources for innovation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous biologicals--science/regulations.

Developments in biologicals·2004
Same author

Best animal care practices in the production and control of biologicals.

Developments in biologicals·2003
Same author

Duration of immunity in dogs inoculated with an inactivated feline parvovirus vaccine.

Veterinary medicine, small animal clinician : VM, SAC·1981
Same author

Efficiency and safety of an inactivated feline parvovirus vaccine against canine parvovirus infection.

Modern veterinary practice·1980
Same author

Evaluation of a bovine virus diarrhea vaccine.

Modern veterinary practice·1978

Area of Science:

  • Veterinary Medicine
  • Animal Welfare Science
  • Regulatory Affairs

Background:

  • Veterinary biologicals manufacturers in the US philosophically support more humane testing methods.
  • Current funding limitations hinder the development and implementation of these advanced methods.
  • Existing animal usage requirements and defensive research costs represent significant financial burdens.

Purpose of the Study:

  • To explore strategies for advancing humane testing in veterinary biologicals manufacturing.
  • To identify opportunities for reallocating resources towards innovation and consumer needs.
  • To advocate for policy adjustments that support the 3Rs (replacement, reduction, refinement) in animal testing.

Main Methods:

  • Analysis of current funding structures and resource allocation within the veterinary biologicals industry.
  • Review of existing regulations pertaining to animal usage in testing.
  • Conceptual framework development for integrating 3Rs principles into manufacturing processes.

Main Results:

  • Limited funding is a primary barrier to adopting more humane testing alternatives.
  • Expanding the focus on 3Rs presents a viable pathway for progress.
  • Adjusting animal usage requirements and defensive research costs can yield significant resource savings.

Conclusions:

  • Shifting focus towards the 3Rs is crucial for advancing humane practices in veterinary biologicals.
  • Policy and cost adjustments are necessary to facilitate the development and adoption of alternatives.
  • Freeing resources through these changes can enhance innovation and better meet consumer demands.

Related Experiment Videos